PRICE T ROWE ASSOCIATES INC /MD/ - GLYCOMIMETICS INC ownership

GLYCOMIMETICS INC's ticker is GLYC and the CUSIP is 38000Q102. A total of 51 filers reported holding GLYCOMIMETICS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of GLYCOMIMETICS INC
ValueSharesWeighting
Q2 2019$36,290,000
-14.9%
3,044,439
-11.1%
0.01%
-16.7%
Q1 2019$42,666,000
+30.1%
3,424,231
-1.1%
0.01%0.0%
Q4 2018$32,791,000
-33.9%
3,462,573
+0.6%
0.01%
-14.3%
Q3 2018$49,588,000
-10.8%
3,443,579
-0.1%
0.01%
-12.5%
Q2 2018$55,608,000
+19.3%
3,447,508
+20.1%
0.01%
+14.3%
Q1 2018$46,593,000
+119.4%
2,870,775
+126.9%
0.01%
+133.3%
Q4 2017$21,239,000
+38.1%
1,264,960
+15.1%
0.00%0.0%
Q3 2017$15,374,000
+1.1%
1,098,910
-19.4%
0.00%0.0%
Q2 2017$15,209,000
+2211.4%
1,362,810
+1392.3%
0.00%
Q4 2014$658,00091,3240.00%
Other shareholders
GLYCOMIMETICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
BVF INC/IL 9,544,262$35,886,0001.41%
NEA Management Company, LLC 9,089,041$34,175,0000.90%
Camber Capital Management LP 2,200,000$8,272,0000.29%
HITE Hedge Asset Management LLC 78,621$296,0000.07%
PRENTISS SMITH & CO INC 14,000$53,0000.02%
Marquette Asset Management, LLC 23,403$88,0000.02%
CAAS CAPITAL MANAGEMENT LP 500,225$1,881,0000.02%
ClariVest Asset Management LLC 130,000$489,0000.02%
Jump Financial, LLC 26,200$99,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 205,200$772,0000.02%
View complete list of GLYCOMIMETICS INC shareholders